Envoy Group Corp (ENVV) First Shipment of Louis XIV Energy Drink to the Caribbean


VALENCIA, California, May 3, 2016 (GLOBE NEWSWIRE) – Envoy Group Corp. (ENVV) is extremely pleased to announce their first shipment of Louis XIV Energy drinks to the Caribbean. We are excited to be launching our first shipment of 60,000 cans to this active market.  We expect the first container to arrive in June 2016.


The Caribbean is home to incredible beaches, climate, hospitable people and a variety of land and ocean recreational activities, it is no wonder the area ranks as one of the top vacation spots on the planet.


Envoy is actively moving into the $50 Billion dollar Energy drink market with the exclusive distribution rights for incredible family of Louis XIV Energy Drinks.  Previously only available in Europe, the Louis XIV Energy Drinks are crafted to produce an ideal balance of high energy and incredible taste.


Envoy plans to develop deep inroads into the vibrant nightlife, sport, restaurant and hotel industry of the Caribbean.


Harp Sangha, CEO of Envoy adds “We see the Caribbean as a key sector for the food and beverage industry with the transformative development of their resident middle class and the thriving tourism market that sees over 25 million visitors annually.”


For further information please visit our website at: www.envoygroupcorp.com

Louis XIV website link: http://www.louisxivenergy.com/en/

Facebook: www.facebook.com/louisxivenergy/


Envoy Group Corp.
28494 Westinghouse Place
Suite 213
Valencia, CA 91355


Corporate Contact:
Harp Sangha
Chairman, Interim CEO & CFO
Email:   hsangha@envoygroupcorp.com

Investor Relations Contact:
Stuart Smith, Investor Relations
Tel:        1-512-267-2430
Email:   ssmith@smallcapvoice.com


Safe Harbor Statements
Certain information contained in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “estimates”, “intends” or “believes”, or that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur”, or “be achieved”. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.